Enso

Enso is a therapeutic neuromodulation and coaching solution startup founded in 2013, based in the United States. Their slogan, "Solving pain without drugs or surgery," encapsulates their mission to provide a non-invasive, drug-free approach to managing chronic pain. The Enso wearable device delivers electrical pulses with a specialized waveform to suppress nerve activity, offering a seamless patient experience. It is IoT-enabled with an app to track treatment use and patient progress. In April 2017, Enso secured a $4.60M Series A investment from notable investors including Freestyle Capital, Techstars, Felicis Ventures, CSC Upshot, and The Cedars-Sinai Accelerator. With the ongoing opioid epidemic, Enso's innovation provides a timely and impactful solution for individuals dealing with chronic pain, offering a sense of confidence and control in pain management.